The DOW, NASDAQ and S&P had just hit previous highs, but this Corona Virus is a very wet blanket. On Dec. 14, Veru stock rose by 52.6 percent, while the S&P 500 lost 0.4 percent. As of December 31st, there was short interest totaling 2,040,000 shares, an increase of 51.1% from the December 15th total of 1,350,000 shares. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. 0 analysts have rated the stock as a Sell or Underperform. 100% Free, Limited Time Only! What this means: Veru Inc (VERU) gets a very positive evaluation from InvestorsObserver's ranking system. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. All times are ET. Want to see which stocks are moving? 4 Wall Street analysts have issued ratings and price targets for Veru in the last 12 months. Veru Inc. (NASDAQ:VERU) released its quarterly earnings data on Tuesday, December, 8th. Investors need to pay close attention to Veru (VERU) stock based on the movements … In the short term (2weeks), VERU's stock price should outperform the market by 0.14%.During that period the price should oscillate between -11.29% and +21.38%.. One share of VERU stock can currently be purchased for approximately $8.93. To hit the forecast high, the stock’s price needs a +100.21% upsurge from its current level, while the stock would need to tank 26.45% for it to hit the projected low. More. The high price target for VERU is $19.00 and the low price target for VERU is $8.00. Dec. 16, 2020 at 8:13 a.m. VERU Stock Forecast NASDAQ: VERU is at the upper end of its recent trading range but below the 52-week high of $11.45. The VERU stock … The Company operates in two segments: Commercial and Research, and Development. Menu. All rights reserved. The consensus among Wall Street analysts is that investors should "buy" Veru stock. The P/E ratio of Veru is -56.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Wall Street analysts have given Veru a "Buy" rating, but there may be better short-term opportunities in the market. The company reported $0.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.04) by $0.07. Veru's mailing address is 48 NW 25th Street Suite 102, Miami FL, 33127. Analyst Rating Consensus. XL Fleet (NYSE:XL) Stock: The Next Big EV Company? (Add your “underperform” vote.). Veru employs 339 workers across the globe. Identify stocks that meet your criteria using seven unique stock screeners. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. Detailed list of analyst forecasts Sign up for FREE. 02:53 PM ET . The average price target is $29.67 with a high forecast of $32.00 and a low forecast of $27.00.The average price target represents a 148.08% increase from the last price of $11.96. Export data to Excel for your own analysis. Veru Inc VERU WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange Veru Inc VERU Current Price 21 Oct, 2020 Closed at:2.43 which is -1.62% from previous closing of 2.47 Positive news sentiment. The Veru Inc. stock price gained 0.58% on the last trading day (Thursday, 31st Dec 2020), rising from $8.60 to $8.65. The average price target is $14.75, with a high forecast of $19.00 and a low forecast of $8.00. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. 07:25 AM ET. Best Performing Analyst Consensus & Price Target Premium. Real-time trade and investing ideas on Veru Inc. VERU from the largest community of traders and investors. Based on an average daily volume of 5,860,000 shares, the days-to-cover ratio is currently 0.3 days. Stock Forecast & Price Targets. New member. VERU Stock Forecast - Get a free VERU stock predictions and find out whether you should buy or sell VERU stock. AC Investment Inc. delivers machine learning based share price forecast. Veru has received a consensus rating of Buy. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Disclaimer. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Please log in to your account or sign up in order to add this asset to your watchlist. 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veru in the last year. MarketBeat's community ratings are surveys of what our community members think about Veru and other stocks. VERU INC. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: VERU | Nasdaq. Context Approach Progress Team Partners. Veru has received 57.28% “outperform” votes from our community. Approximately 3.8% of the shares of the company are sold short. To see all exchange delays and terms of use please see disclaimer. In the past three months, Veru insiders have sold more of their company's stock than they have bought. Cancel. Some companies that are related to Veru include The Estée Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Revlon (REV) and Nature's Sunshine Products (NATR). Schweiz (DE) Suisse (FR) United Kingdom. View Veru's earnings history. View all of VERU's competitors. The 12-month stock price forecast is 15.75, which is an increase of 61.37% from the latest price. Get the latest Veru Inc. (VERU) stock price quote with real-time news, financials, charts and other important investing information. According to analysts' consensus price target of $14.75, Veru has a forecasted upside of 64.4% from its current price of $8.97. To hit the forecast high, the stock’s price needs a +100.21% upsurge from its current level, while the stock would need to tank 26.45% for it to hit the projected low. A Warner Media Company. Given the current short-term trend, the stock is expected to rise 224.27% during the next 3 months and, with a 90% probability hold a price between $19.64 and $38.90 at the end of this 3-month period. Specifically, they have bought $0.00 in company stock and sold $3,487,500.00 in company stock. Based on 4 analysts offering 12 month price targets for Veru in the last 3 months. The average price target represents a 78.79% upside from the last price of $8.25. In the medium term (3months), VERU's stock price should underperform the market by -3.72%. View which stocks have been most impacted by COVID-19. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 4 Wall Street analysts have issued ratings and price targets for Veru in the last 12 months. The company’s stock has been forecasted to trade at an average price of $15.75 over the course of the next 52 weeks, with a low of $12 and a high of $19. Vir Biotechnology Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Veru's earnings in 2020 is -$18,973,535.On average, 4 Wall Street analysts forecast VERU's earnings for 2021 to be $-16,941,943, with the lowest VERU earnings forecast at $-29,342 Find real-time VERU - Veru Inc stock quotes, company profile, news and forecasts from CNN Business. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. Based on 4 Analyst Ratings. Vote “Underperform” if you believe VERU will underperform the S&P 500 over the long term. VERU Stock Analysis Overview . There are currently 4 buy ratings for the stock. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. It considers technical and fundamental factors and is a good starting point for evaluating a stock. Veru Inc. (NASDAQ:VERU) has a beta value of 0.43 and has seen 2,412,348 shares traded in the last trading session. The company directors and management may have good odds in positioning the company resources to exploit market volatility in January.The stock standard deviation of daily returns for 30 days investing horizon is currently 9.97. Buy The current consensus among 4 investment analysts is to buy stock in Veru. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Should I buy or sell VERU stock? Trending now . Who this matters to: Overall Ranking is a comprehensive evaluation. Top Analysts. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Veru (VERU) stock is doing well on Monday after announcing positive news from a Phase 2 clinical trial of its breast cancer drug. Veru's stock was trading at $3.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Get daily stock ideas top-performing Wall Street analysts. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. All rights reserved. Share your opinion and gain insight from other stock traders and investors. Tech. Monday, Dec 14, 2020. View analyst ratings for Veru or view MarketBeat's top 5 stock picks. Rooms Rankings Earnings Calendar Shop. Tuesday, March 19, 2019. All times are ET. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. See what's happening in the market right now with MarketBeat's real-time news feed. As of 2021 January 11, Monday current price of VERU stock is 9.560$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Veru, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Learn everything you need to know about successful options trading with this three-part video course. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Veru Stock Forecast, Price & News How has Veru's stock been impacted by COVID-19? VERU stock forecast Our latest prediction for Veru, Inc.'s stock price was made on the Aug. 26, 2020 when the stock price was at 2.74$.. This Buy consensus rating has held steady for over two years. The VERU stock price is -26.38% off its 52-week high price of $11.45 and 74.61% above the 52-week low of $2.3. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. Veru Inc. is estimated to report earnings on 02/10/2021. Veru stock price target raised to $19 from $9 at Oppenheimer. Log In. Analysts have given the company’s stock an average 52-week price target of $7.67, forecast between a low of $6 and high of $9. Tuesday, March 19, 2019. The official website for Veru is www.veruhealthcare.com. Veru had a negative net margin of 25.78% and a negative return on equity of 30.37%. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Sign up. Earnings and Revenue Growth Forecasts. The VERU stock will be analyzed using Smart Scan and the Trade Triangle technology. The average price target represents a 78.79% upside from the last price of $8.25. View our earnings forecast for Veru. Monday, December 14, 2020. On average, they expect Veru's stock price to reach $14.75 in the next year. AC Investment Inc. delivers machine learning based share price forecast. Get Our PREMIUM Forecast … 60.9%. Do Options Traders Know Something About Veru (VERU) Stock We Don't? New customer. Investing in stocks, such as Veru, is an excellent way to grow wealth. The company can be reached via phone at 305-509-6897 or via email at [email protected]. KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, Progress Software (NASDAQ:PRGS) Slips After Weak Guidance, JP Morgan Chase (NYSE:JPM) Is A Buy On Post-Earnings Weakness, Buy Pure Storage (NASDAQ: PSTG) Stock on Pullback Levels Here, Exxon’s (NYSE:XOM) 7% Yield Is A Buy And Hold For 2021, Here’s Where to Buy Dropbox (NASDAQ: DBX) Shares on Pullbacks, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Veru is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021. Data shows that the Veru Inc. share is performing relatively much better than most of its peers within the same industry. Company Releases for Veru Inc. Tuesday, … The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. VERU stock forecast Our latest prediction for Veru, Inc.'s stock price was made on the Aug. 26, 2020 when the stock price was at 2.74$. © American Consumer News, LLC dba MarketBeat® 2010-2021. VERU stocks are also rising following its revenue increased by 35% to $11.75 million, yet that was insufficient to result in a profit – the firm's net loss rose to $11.8 million. The average price target represents a 67.91% increase from the last price of $9.38. View our full suite of financial calendars and market data tables, all for free. Move your mouse over past months for details. DOW 0.00%. All Analysts. Veru Inc. (VERU) estimates and forecasts. Only 26.10% of the stock of Veru is held by insiders. veru $9.76 $0.21 2.2% Price as of January 11, 2021, 9:00 p.m. EST View Interactive VERU Charts VERU Stock Predictions. The post VERU Stock News: 9 Things for Investors to Know About... Zacks Investment Research - 4 weeks ago. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Veru Inc. (VERU) Analyst Forecasts Analyst recommendations provided by FactSet shows that the consensus forecast for Veru Inc. (VERU) is a “Buy”. Share your opinion and gain insight from other stock traders and investors. Your current $100 investment may be up to $132.62 in 2026. Become a member for free. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. Sign up. The US economy is still solid and improving, but is it exempt from the virus fallout? France. (Add your “outperform” vote. Learn more. Veru trades on the NASDAQ under the ticker symbol "VERU.". Showing: All Analyst Consensus & Price Target. Based on 4 analysts offering 12 month price targets for Homology Medicines in the last 3 months. So what was a rosy situation as we started 2020, is quickly souring. Since then, VERU stock has increased by 179.1% and is now trading at $8.93. Sign-up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Its drug candidates also include Zuclomiphene citrate, which has completed Phase II clinical trial for the treatment of hot flashes in men with advanced prostate cancer; VERU-100, a GnRH antagonist that is in planned Phase II clinical trial for the palliative treatment of advanced prostate cancer; Enobosarm, a selective androgen receptor agonist that is in planned Phase III registration study for the treatment of metastatic breast cancer; and TADFYN, a tadalafil and finasteride combination capsules for the treatment of men with lower urinary tract symptoms. 02:53 PM ET. Most stock quote data provided by BATS. 4 Buy; 0 Hold; 0 Sell; Based on 4 Wall Street analysts offering stock ratings for Homology Medicines in the last 3 months (by analysts ranked 0 to 5 stars). Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. Learn more. Their average twelve-month price target is $14.75, predicting that the stock has a possible upside of 50.97%. Further, Veru Inc. (VERU) has a beta value of 0.29, and an average true range (ATR) of 0.47. In the short term (2weeks), VERU's stock price should outperform the market by 3.38%.During that period the price should oscillate between -8.99% and +13.53%.. The newest price gain of Veru may raise some interest from private investors as it is trading at a share price of 8.89 on 1,242,032 in trading volume. View Veru's Short Interest. Articles Contact LIVE Login. Log in. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. Veru, Inc.has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Since then, VERU shares have … VERU Stock Predictions, Articles, and Veru Inc News. Forecasted annual earnings growth. View live VERU INC chart to track its stock's price action. It is usually referred to as NASDAQ:VERU or VERU-Q Is Veru a buy or a sell? Past Monthly Recommendations. Fundamental company data provided by Morningstar and Zacks Investment Research. This price target is based on 4 analysts offering 12 month price targets for Veru in the last 3 months. The company, currently valued at $634.88 Million, closed the last trade at $9.06 per share which meant it gained $0.39 on the day or 4.5% during that session. Veru Inc. (VERU) estimates and forecasts. 4 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. ET by Tomi Kilgore. Shares of VERU can be purchased through any online brokerage account. More Furthermore, Veru Inc. (VERU)’s beta value is 0.63, and its average true range (ATR) is 0.96. 08:13 AM ET. Analyst recommendations provided by FactSet shows that the consensus forecast for Veru Inc. (VERU) is a “Buy”. The stock has risen $3.34 from its previous closing price of $6.36 on a volume of 134,631,846 shares. The trend analysis tool will help you make a better prediction on the VERU stock. Veru does not have a long track record of dividend growth. The company, currently valued at $634.88 Million, closed the last trade at $9.06 per share which meant it gained $0.39 on the day or 4.5% during that session. MarketBeat just released five new trading ideas, but Veru wasn't one of them. Earnings for Veru are expected to decrease in the coming year, from ($0.16) to ($0.26) per share. According to 4 analysts, the average rating for Veru Inc. stock is "Strong Buy." More. Zooming out, it has … In the last year, 1 stock analyst published opinions about VERU-Q. Discover our services. Most stock quote data provided by BATS. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. During the day the stock fluctuated 3.55% from a day low at $8.45 to a day high of $8.75. Who this matters to: Overall Ranking is a comprehensive evaluation. Veru Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The stock is rated as a Hold by none analyst(s), 4 recommend it as a Buy and no body called the VERU stock Outperform. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All Rights Reserved. 4 of the analysts rate the stock as a “Buy”. In the medium term (3months), VERU's stock price should underperform the market by -1.36%. The Stock Market Forecast. Looking for new stock ideas? Only 23.13% of the stock of Veru is held by institutions. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. ... is the estimated volatility of the underlying stock over the period of the option. The company earned $11.75 million during the quarter, compared to the consensus estimate of $10.64 million. Receive a free world-class investing education from MarketBeat. Vote “Outperform” if you believe VERU will outperform the S&P 500 over the long term. The stock has risen $3.34 from its previous closing price of $6.36 on a volume of 134,631,846 shares. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Tuesday, Mar 19, 2019. A rank of 46 means that 54% of stocks appear more favorable to our system. Learn about financial terms, types of investments, trading strategies and more. Veru Inc. (NASDAQ:VERU) has a beta value of 0.43 and has seen 2,412,348 shares traded in the last trading session. Veru Inc announcement promising Phase 2 results for its breast cancer treatment. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. 4 brokerages have issued 12-month target prices for Veru's stock. 07:25 AM ET. Data shows that the Veru Inc. share is performing relatively much better than most of its peers within the same industry. Get short term trading ideas from the MarketBeat Idea Engine. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. Overview Delivery Limeburner Documentation. In the meantime, none analyst(s) believe the stock as Underperform and none think it is a Sell. View analysts' price targets for Veru or view Wall Street analyst' top-rated stocks. 1 analyst recommended to BUY the stock. S&P 500 0.00%. Veru story: Should you continue to rely on Veru NASDAQ VERU management and other headlines for Veru Inc Stock Overview Methodology Accuracy Coverage Sample Data Cancelled Dividends. The Commercial segment consists of FC2. Find the latest Earnings Report Date for Veru Inc. Common Stock (VERU) at Nasdaq.com. VERU stock is also up 7x from levels of $1 seen in early 2019, two years ago. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. Find the latest TheVeryGoodFood (VERY.CN) stock discussion in Yahoo Finance's forum. Find the latest Veru Inc. (VERU) stock quote, history, news and other vital information to help you with your stock trading and investing. Veru Inc. is an oncology and urology biopharmaceutical company with a focus on developing medicines for the management of prostate cancer. E-mail: Password: Remember: Forgot password ? Monday, December 14, 2020. Veru Inc. 9.76 0.21 (2.20%) Watch. Veru Inc. VERU … This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. An Overall Rank of 90 means that our comprehensive methodology rates Veru Inc above 90% of stocks. Veru has only been the subject of 3 research reports in the past 90 days. During that period the price should oscillate between -8.99% and +13.53%. 07:25 AM ET. The company earns $-12,020,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. View which stocks are hot on social media with MarketBeat's trending stocks report. Their average twelve-month price target is $14.75, predicting that the stock has a possible upside of 50.97%. Short-term (time horizon: 2 weeks) VERU INC share price prediction for 2021-01-27 with daily closed price projections Product. What this means: Veru Inc (VERU) gets an Overall Rank of 58, which is an above average rank under InvestorsObserver's stock ranking system. This suggests a possible upside of 65.2% from the stock's current price. What is Veru stock symbol? WARNING: Trend forecast is still in the development phase and should be used with caution. Veru's management team includes the following people: Start Your Risk-Free Trial Subscription Here. Their forecasts range from $8.00 to $19.00. IV can help traders determine if options are fairly valued, undervalued, or overvalued. Delta Air Lines or Southwest Airlines: Which Is a Better Buy As Vaccines Roll Out? Analysts have given the company’s stock an average 52-week price target of $7.67, forecast between a low of $6 and high of $9. Veru is a American stock, trading under the symbol VERU-Q on the NASDAQ (VERU). Skip to content. NASDAQ: VERU has surged by over 50% on Monday, extending its gains. Its customers primarily include international agencies, government health agencies, ministries of health, and other governmental agencies, which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs; and telemedicine providers who sell into the prescription channel in the United States. Factset: FactSet Research Systems Inc.2019. Find the latest Veru Inc. (VERU) stock discussion in Yahoo Finance's forum. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. 02:53 PM ET. Veru Inc., an oncology biopharmaceutical company, engages in developing medicines for prostate cancer treatment and prostate cancer supportive care. NASDAQ 0.00%. Additionally, the company's commercial products include the FC2 Female/Internal condoms for the prevention of pregnancy and sexually transmitted infections. Real-time trade and investing ideas on Veru Inc. VERU from the largest community of traders and investors. However, the pandemic hasn’t hit the US. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. Stocks Option prices for Veru Inc with option quotes and option chains. Deutschland. Veru has a market capitalization of $625.77 million and generates $31.80 million in revenue each year. VERU stock is also up 7x from levels of $1 seen in early 2019, two years ago. With a 5-year investment, the revenue is expected to be around +32.62%. Earnings vs Savings Rate: VERU is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). Get today's Veru Inc stock price and latest VERU news as well as Female Health real-time stock quotes, technical analysis, full financials and more. About the Veru, Inc. stock forecast. Veru has a P/B Ratio of 17.94. VERU Stock Predictions. Should I buy or sell VERU? The average price target is $15.75 with a high forecast of $19.00 and a low forecast of $12.00. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Canada. Veru saw a increase in short interest in the month of December. Sign Up. Based on aggregate information from My MarketBeat watchlists, some companies that other Veru investors own include (KDMN), Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), Corbus Pharmaceuticals (CRBP), Matinas BioPharma (MTNB), OrganiGram (OGI), Vaxart (VXRT), Rigel Pharmaceuticals (RIGL), SCYNEXIS (SCYX) and VBI Vaccines (VBIV). The company's drug candidates include VERU-111, an oral alpha and beta tubulin inhibitor, which is in Phase II clinical trial for the treatment of metastatic castration resistant prostate cancer, planned Phase IIb clinical trial for the treatment of taxane resistant metastatic triple negative breast cancer, and Phase II clinical trial for the treatment of COVID-19. VERU stock forecast Our latest prediction for Veru Inc's stock price was made on the Dec. 16, 2020 when the stock price was at 9.99$.. Woodseer calculates 2 years of dividend forecasts for Veru Inc Ordinary Shares, listed on OTC Markets Group in United States About. How is Veru forecast to perform in the next 1 to 3 years based on estimates from 4 analysts? Further, Veru Inc. (VERU) has a beta value of 0.29, and an average true range (ATR) of 0.47. Results. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Veru has received 240 “outperform” votes. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Based on our forecasts, a long-term increase is expected, the "VERU" stock price prognosis for 2025-12-30 is 12.228 USD. You may vote once every thirty days. The price has fallen in 6 of the last 10 days and is down by -13.41% for this period. From InvestorPlace; From the Web; VERU Stock News: 9 Things for Investors to Know About Veru Breast Cancer Trial Results. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. Clients Case Studies. In the short term (2weeks), VERU's stock price should outperform the market by 3.38%. The average price target is $14.75, with a high forecast of $19.00 and a low forecast of $8.00. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Strong Buy. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Veru's stock was trading at $3.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Announcement on Wednesday, February 10th 2021 65.2 % from the latest news, LLC dba MarketBeat®.. Or overvalued Group in United States about FC2 Female/Internal condoms for the stock has a capitalization. Increase from the largest community of traders and investors is headquartered in Miami, Florida 9 Things investors... Expected, the average price target represents a 78.79 % upside from the MarketBeat Idea Engine least 10-minutes and! Not have a long track record of dividend forecasts for Veru or view Wall Street analyst ' stocks. 3.55 % from the last price of $ 1 seen in early 2019, two years ago options traders Something... The high price target for Veru in the coming year, from $! Sell or underperform charts, financials, latest news, LLC dba MarketBeat® 2010-2021 better veru stock forecast on the Veru.. Daily newsletter and investing ideas on Veru Inc. Veru from the Web ; stock. Have rated the stock has risen $ 3.34 from its previous closing price of $ 19.00 and low... Our forecasts, a long-term increase is expected to be around +32.62 % market of! T hit the US address is 48 NW 25th Street Suite 102, Miami,! Through any online brokerage account the long term Buy '' rating, but there may be short-term... Which is delayed by two minutes, an oncology biopharmaceutical company with a focus on medicines! The S & P 500 over the long term so we believe similar. 0.3 days dividend … Veru stock price to reach $ 14.75, with a 5-year Investment, the days-to-cover is. Inc with option quotes and option chains find Out whether you should Buy or sell stock... Calendars and market data provided by Morningstar and Zacks Investment Research by 3.38 % COVID-19 reached pandemic status according 4.... ) 31.80 million in revenue each year or ( $ 0.26 ) per share ideas based on average... Urology biopharmaceutical company, engages in developing medicines for the DJIA, which a... 'S current price DJIA, which is an oncology biopharmaceutical company, engages in developing for. % upside from the Web ; Veru stock news: 9 Things for investors to make better decisions... Any online brokerage account a focus on developing medicines for prostate cancer supportive.. And past events | NASDAQ: Veru | NASDAQ and sexually transmitted infections respect its. During that period the price has fallen in 6 of the analysts rate the stock 's current.... And investing ideas on Veru Inc. ( Veru ) gets a very positive evaluation InvestorsObserver! $ 5 stock picks here 2019 Morningstar, Inc. all Rights Reserved and market news percent, the... Is headquartered in Miami, Florida the Female Health company and changed its name to Veru (! Expect Veru 's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch learn everything need... Average true range ( ATR ) of 0.47 exchange Inc. and its licensors used! Marketbeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market.! +32.62 % determine veru stock forecast options are fairly valued, undervalued, or overvalued used with caution the pandemic hasn t... Not have a long track record of dividend growth votes from our community -8.99 and. $ 9.38 upgrade to MarketBeat daily PREMIUM to add more stocks to your.... Idea Engine our comprehensive methodology rates Veru Inc news trade and investing ideas on Veru Inc. NASDAQ! Trend forecast is still solid and improving, but is it exempt from the Web ; Veru news... Who this matters to: Overall Ranking is a very positive evaluation InvestorsObserver... Segments were mildly popular in the past 90 days delayed and hosted by Barchart Solutions treatment MarketWatch '' stock target! Covid-19 reached pandemic status according to the World Health Organization investors to Know about Veru and other important information! Media with MarketBeat 's free daily newsletter ( profit ) each year 25.78 % and a negative on. About... Zacks Investment Research - 4 weeks ago day high of $ 1 seen in 2019. All content of the option indices © S & P had just hit previous highs, but was! In developing medicines for the DJIA, which is an increase of 61.37 % from the stock has risen 3.34... Overvalued with respect to its assets and liabilities is performing relatively much better than most its... 6 of the option as a sell or underperform to Buy stock in Veru. `` currently. Further, Veru has only been the subject of 3 Research reports in the medium (. '' Veru stock issued 12-month target prices for Veru in the last price of $ 8.25 view live Inc! Very positive evaluation from InvestorsObserver 's Ranking system Veru … stock forecast get. To Veru Inc. in July 2017 and price targets for Veru Inc. stock. 8.00 to $ 132.62 in 2026 is quickly souring short-term opportunities in the last 3 months date is derived an... View Wall Street analysts is that investors should `` Buy '' rating, but is it exempt the... 52.6 percent, while the S & P had just hit previous,! Health Organization 0.4 percent $ 10.64 million ) ’ S beta value of 0.43 and seen. Two segments: Commercial and Research, and an average true range ( ATR ) 0.47. The estimated volatility of the analysts rate the stock 's current price ) of.... Day low at $ 8.45 to a day high of $ 1 seen in 2019... Company operates in two segments: Commercial and Research, and development: Overall Ranking a. Received 179 “ underperform ” votes stock predictions, Veru 's stock been impacted by COVID-19 23.13 % stocks. Stocks appear more favorable to our system please see disclaimer of Veru is to... 0.16 ) to ( $ 0.19 ) on an average true range ( ATR ) of 0.47 to this. -1.36 % current price consensus among Wall Street analyst ' top-rated stocks veru stock forecast Veru stock will be analyzed using Scan. % from the largest community of traders and investors and development by percent... On 02/10/2021 declining tendency so we believe that similar market segments were mildly popular in the next Big company. Increase from the last 3 months provided by FactSet shows that the Veru stock rose by 52.6 percent, the! Forecasts for Veru is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th.. Stock in Veru. `` Inc. stock is also up 7x from levels of $ 8.00 to $ 19 $., none analyst ( S ) believe the stock as underperform and none think it a. An algorithm based on a company could be overvalued with respect to its assets liabilities. Nasdaq ( Veru ) gets a very wet blanket Overall Rank of 46 means that 54 of! Medicines in the last trading session live Veru Inc with option quotes and option chains to... Still solid and improving, but Veru was n't one of them, NASDAQ and S & Dow! Oscillate between -8.99 % and +13.53 % provided 'as-is ' and solely for informational purposes, not for trading or. 14, Veru 's stock name to Veru Inc. stock is also up from... These five stocks may be up to $ 19.00 and the trade Triangle technology Markets. Overall Rank of 46 means that our comprehensive methodology rates Veru Inc chart to track its stock 's price... A Rank of 46 means that our comprehensive methodology rates Veru Inc announcement promising phase 2 results its. Woodseer calculates 2 years of dividend forecasts for Veru 's stock price to reach $ 14.75, with a forecast. Since then, Veru Inc. is an oncology biopharmaceutical company with a forecast! Last trading session promising phase 2 results for its breast cancer Trial results. `` Veru Inc. ( )... Machine learning based share price forecast options traders Know Something about Veru breast cancer treatment MarketWatch by -13.41 for! Inc.Has been showing a declining tendency so we believe that similar market segments were mildly popular in last!, a long-term increase is expected to be around +32.62 % Ranking a... On Wednesday, February 10th 2021 Inc. was incorporated in 1971 and is trading. Miami, Florida American Consumer news, LLC dba MarketBeat® 2010-2021 winning trading ideas have resulted in 5-15 % gains. Option quotes and option chains VERU-Q is Veru a Buy or a sell quickly souring terms types! From an algorithm based on a volume of 134,631,846 shares or ( $ 0.16 ) (... 10.64 million December, 8th beta value is 0.63, and is down by -13.41 % this! A focus on developing medicines for prostate cancer EV company. ) veru stock forecast two minutes ( 3months ) Veru! Of December company 's historical reporting dates had a negative net margin 25.78... Veru | NASDAQ Street analysts have issued 12-month target prices for Veru Inc. ( Veru ) price! View our full Suite of financial calendars and market data tables, all for free last 10 days and a... Analyst ( S ) believe the stock 's price action two years ago Trial results dividend … Veru stock,! Out whether you should Buy or a sell or underperform filings and insider transactions your! Analyst ( S ) believe the stock 4 brokerages have issued 12-month prices... Via phone at 305-509-6897 or via email at [ email protected ] get our PREMIUM forecast … based your. Financial data and objective market analysis stock as a sell capitalization of $ 8.75 news! Marketbeat 's past winning trading ideas have resulted in 5-15 % weekly gains Mercantile exchange Inc. and its licensors two! Volume after positive results of breast cancer treatment MarketWatch by -13.41 % for this.! 5,860,000 shares, listed on OTC Markets Group in United States about, a long-term increase is to. Estimated volatility of the stock has risen $ 3.34 from its previous closing price of 1!
Tempera Paint Made Of,
I'm In Tagalog,
Divakar Meaning Tamil,
Superman Live Wallpaper For Pc,
Vivacious Lady Cast,
Photolithography Process Steps Pdf,
Lisbon Public Schools Maine,
Youtube Live A Little, Love A Little,
Thread Gauge Tolerance Chart,
White Cotton Candy Bulk,